Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fuji
Baxter
Mallinckrodt
Healthtrust
Express Scripts
Dow
Julphar
Merck

Generated: November 18, 2018

DrugPatentWatch Database Preview

ZOLPIDEM TARTRATE Drug Profile

« Back to Dashboard

When do Zolpidem Tartrate patents expire, and when can generic versions of Zolpidem Tartrate launch?

Zolpidem Tartrate is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Anchen Pharms, Apotex Inc, Lupin Ltd, Sandoz, Sun Pharma Global, Synthon Pharms, Acme Labs, Aurobindo Pharma, Cipla Ltd, Dr Reddys Labs Ltd, Hikma, Invagen Pharms, Mylan, Mylan Pharms Inc, Sandoz Inc, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Torrent Pharms, Vintage, Vivimed Global, Watson Labs, Wockhardt, Yung Shin Pharm, Dr Reddys Labs Inc, Novel Labs Inc, Par Form, and Par Pharm Inc. and is included in thirty-four NDAs.

The generic ingredient in ZOLPIDEM TARTRATE is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the zolpidem tartrate profile page.

Drug patent expirations by year for ZOLPIDEM TARTRATE
Pharmacology for ZOLPIDEM TARTRATE
Synonyms for ZOLPIDEM TARTRATE
(2R,3R)-2,3-dihydroxybutanedioic acid; N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide
103188-50-7
2,3-bis(oxidanyl)butanedioic acid; N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]ethanamide
2,3-dihydroxybutanedioic acid; N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)-3-imidazo[1,2-a]pyridinyl]acetamide
2,3-dihydroxybutanedioic acid; N,N-dimethyl-2-[6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl]acetamide
99294-93-6
A845992
AB04867
AC1L1N3L
ACT03353
AK126641
AKOS016013007
Ambap99294-93-6
AN-34491
API0004657
AX8157421
BEMA-Zolpidem
Bio-0153
CCG-100938
CHEMBL1723343
CPD000469145
EX-A1146
FK-199B
HE291113
HE421061
HMS2051H09
HMS2232G04
HMS3374C07
HMS3393H09
MFCD00214408
MLS001401453
N,N-dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetamide (2S,3S)-2,3-dihydroxysuccinate
N,N-Dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetamide 2,3-dihydroxysuccinate
NC00188
NYVVVBWEVRSKIU-UHFFFAOYSA-N
OX-22
SAM001246549
SCHEMBL1653530
SCHEMBL40721
SL-80-0750-23N
SL-800750-23N
SMR000469145
T94Z936
Zolpidem MR
Zolpidem ODT

US Patents and Regulatory Information for ZOLPIDEM TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 077288-001 Apr 23, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 076578-002 Apr 23, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 078616-001 Nov 21, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Inc ZOLPIDEM TARTRATE zolpidem tartrate TABLET;SUBLINGUAL 204503-002 Nov 18, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 076410-001 Apr 23, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 078616-002 Nov 21, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 078426-001 May 15, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fuji
Baxter
Mallinckrodt
Healthtrust
Express Scripts
Dow
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.